Gene Network Analysis of Metallo Beta Lactamase Family Proteins Indicates the Role of Gene Partners in Antibiotic Resistance and Reveals Important Drug Targets
暂无分享,去创建一个
Anand Anbarasu | Sudha Ramaiah | Sudha Ramaiah | A. Anbarasu | Anitha Parimelzaghan | Anitha Parimelzaghan
[1] D. Court,et al. Essentiality of Ribosomal and Transcription Antitermination Proteins Analyzed by Systematic Gene Replacement in Escherichia coli , 2007, Journal of bacteriology.
[2] Andrew V. Sutherland,et al. Bacterial diaminopimelate metabolism as a target for antibiotic design. , 2000, Bioorganic & medicinal chemistry.
[3] M. Rohmer,et al. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs. , 2004, Current opinion in investigational drugs.
[4] V. Godoy,et al. Antibiotic Resistance Acquired through a DNA Damage-Inducible Response in Acinetobacter baumannii , 2013, Journal of bacteriology.
[5] K. P. Lennox,et al. Computational analysis of pathogen-borne metallo β-lactamases reveals discriminating structural features between B1 types , 2012, BMC Research Notes.
[6] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[7] J. Frère,et al. Mutational Analysis of VIM-2 Reveals an Essential Determinant for Metallo-β-Lactamase Stability and Folding , 2010, Antimicrobial Agents and Chemotherapy.
[8] Gary D. Bader,et al. An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.
[9] P. Nordmann,et al. Metallo-beta-lactamases: the quiet before the storm? , 2005, Clinical microbiology reviews.
[10] K. Asai,et al. A Bacitracin-Resistant Bacillus subtilis Gene Encodes a Homologue of the Membrane-Spanning Subunit of the Bacillus licheniformis ABC Transporter , 2003, Journal of bacteriology.
[11] Carine Bebrone,et al. Update of the Standard Numbering Scheme for Class B β-Lactamases , 2004, Antimicrobial Agents and Chemotherapy.
[12] R. Utsumi,et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator , 2010, Journal of antibiotics (Tokyo. 1968).
[13] R. Hakenbeck,et al. The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance. , 2000, FEMS microbiology letters.
[14] V. Nizet,et al. Pharmacological Inhibition of the ClpXP Protease Increases Bacterial Susceptibility to Host Cathelicidin Antimicrobial Peptides and Cell Envelope-Active Antibiotics , 2012, Antimicrobial Agents and Chemotherapy.
[15] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[16] J. Davies,et al. Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.
[17] Ben Tagger,et al. Federated ontology-based queries over cancer data , 2012, BMC Bioinformatics.
[18] B. Weisblum. Erythromycin resistance by ribosome modification , 1995, Antimicrobial agents and chemotherapy.
[19] D. Qu,et al. Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein , 2014, Applied Microbiology and Biotechnology.
[20] C. Bebrone. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. , 2007, Biochemical pharmacology.
[21] Hiromi Daiyasu,et al. Expansion of the zinc metallo‐hydrolase family of the β‐lactamase fold , 2001 .
[22] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[23] Natasa Przulj,et al. Biological network comparison using graphlet degree distribution , 2007, Bioinform..
[24] D. M. Goodenough-Lashua,et al. tRNA-guanine transglycosylase from E. coli: a ping-pong kinetic mechanism is consistent with nucleophilic catalysis. , 2003, Bioorganic chemistry.
[25] Xiaowen Chen,et al. Topological properties of the drug targets regulated by microRNA in human protein–protein interaction network , 2011, Journal of drug targeting.
[26] J. Frère,et al. Standard numbering scheme for class B beta-lactamases. , 2001, Antimicrobial agents and chemotherapy.
[27] Maria J. Gomez,et al. Genes Involved in Intrinsic Antibiotic Resistance of Acinetobacter baylyi , 2006, Antimicrobial Agents and Chemotherapy.
[28] M. Kale,et al. Exploration of Lysine Pathway for Developing Newer Anti-Microbial Analogs through Enzyme Inhibition Approach , 2014 .
[29] R. Kohli,et al. Targets for Combating the Evolution of Acquired Antibiotic Resistance , 2015, Biochemistry.
[30] Fidel Ramírez,et al. Computing topological parameters of biological networks , 2008, Bioinform..
[31] M. Sugai,et al. Characterization of fmtA, a Gene That Modulates the Expression of Methicillin Resistance in Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.
[32] H. Yoneyama,et al. Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development , 2006, Bioscience, biotechnology, and biochemistry.
[33] Cathy H. Wu,et al. UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..
[34] Sang Yup Lee,et al. Rapid one‐step inactivation of single or multiple genes in Escherichia coli , 2013, Biotechnology journal.
[35] O. Sahin,et al. Key Role of Mfd in the Development of Fluoroquinolone Resistance in Campylobacter jejuni , 2008, PLoS pathogens.
[36] D. Žgur-Bertok,et al. DNA Damage Repair and Bacterial Pathogens , 2013, PLoS pathogens.
[37] Timothy R. Walsh,et al. Metallo-β-Lactamases: the Quiet before the Storm? , 2005, Clinical Microbiology Reviews.
[38] A. Vila,et al. Evolution of Metallo-β-lactamases: Trends Revealed by Natural Diversity and in vitro Evolution , 2014, Antibiotics.
[39] William Sinko,et al. Antibacterial drug leads targeting isoprenoid biosynthesis , 2012, Proceedings of the National Academy of Sciences.
[40] J. Barbé,et al. Acinetobacter baumannii RecA Protein in Repair of DNA Damage, Antimicrobial Resistance, General Stress Response, and Virulence , 2011, Journal of bacteriology.
[41] Giovanni Scardoni,et al. Node Interference and Robustness: Performing Virtual Knock-Out Experiments on Biological Networks: The Case of Leukocyte Integrin Activation Network , 2014, PloS one.
[42] J. Pleiss,et al. Systematic Analysis of Metallo-β-Lactamases Using an Automated Database , 2012, Antimicrobial Agents and Chemotherapy.
[43] H Toh,et al. Expansion of the zinc metallo-hydrolase family of the beta-lactamase fold. , 2001, FEBS letters.
[44] C. Hutton,et al. Inhibitors of lysine biosynthesis as antibacterial agents. , 2003, Mini reviews in medicinal chemistry.
[45] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[46] T. Palzkill. Metallo‐β‐lactamase structure and function , 2013, Annals of the New York Academy of Sciences.
[47] D. Lipman,et al. Extracting protein alignment models from the sequence database. , 1997, Nucleic acids research.
[48] J. Goldsmith,et al. Ampicillin Resistance Is Increased in Escherichia coli K 12 relA and spoT Mutants but Sub-inhibitory Pretreatment Does Not Induce Adaptive Resistance , 2013 .
[49] Damian Szklarczyk,et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..
[50] T. Pitt,et al. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance. , 2006, The Journal of antimicrobial chemotherapy.
[51] K. Becker,et al. The mecA Homolog mecC Confers Resistance against β-Lactams in Staphylococcus aureus Irrespective of the Genetic Strain Background , 2014, Antimicrobial Agents and Chemotherapy.
[52] L. Engstrand,et al. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] D. Green. The bacterial cell wall as a source of antibacterial targets , 2002, Expert opinion on therapeutic targets.